ReviewNaunyn-Schmiedeberg's archives of pharmacology2026
A comprehensive review on plant-derived bioactive saponins as promising antimicrobial agents: from bioavailability challenges, molecular mechanistic insights to therapeutic applications.
Review in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Multifunctional Silk Fibroin Hydrogel with Antibacterial and Regenerative Properties for Accelerated Wound Healing.Gels (Basel, Switzerland) · 2026Article
- Mechanisms of Bacterial Resistance and Innovative Strategies to Overcome Antimicrobial Resistance.Antibiotics (Basel, Switzerland) · 2026Review
- Review
- Assessment of the Antimicrobial Activity ofInternational journal of molecular sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
A major worldwide health concern is antimicrobial resistance (AMR), driving an urgent need for novel therapeutic agents. Saponins, glycosylated phytochemicals with amphiphilic structures, have emerged as promising candidates owing to their wide-ranging antimicrobial effects. These substances exhibit potent antibacterial activity against multidrug-resistant pathogens, including methicillin-resistant Staphylococcus aureus, and antifungal activity against pathogens like Candida and Trichophyton species. Furthermore, saponins demonstrate potential in combating viral diseases, attributed to their ability to disrupt lipid membranes and modulate host immune responses. Recent advances in saponin research highlight innovations in extraction techniques, formulation strategies, and combination therapies, enhancing their bioavailability and therapeutic potential. Computational studies have further elucidated their mechanisms of action, supporting the development of saponin-based drug delivery systems and synergistic applications with existing antimicrobials. With their structural diversity, bioactivity, and versatility in medical, agriculture, and biotechnology applications, saponins represent a critical natural resource for addressing the AMR crisis and advancing future antimicrobial therapies. Therefore, this review aims to comprehensively summarize recent findings on the antimicrobial properties of plant-derived saponins, clarify their mechanisms of action, bioavailability challenges, and highlight their therapeutic potential and future directions.
Indexed as
Identifiers
40839006What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.